Research Progress on the Therapeutic Efficacy of Astragalus and Coptis Combined Therapy for Non-alcoholic Fatty Liver Disease from the Perspective of Immune-inflammation Mechanisms
It has been found that the Astragalus-Coptis combination can alleviate hepatic inflammatory responses via several pathways: blocking the function of the TLR4/NF-κB signalling pathway, regulating the formation and secretion of NLRP3 inflammasome and decreasing the amount of endotoxin translocation in the enterohepatic c...